
### [MONDO:0016803](http://purl.obolibrary.org/obo/MONDO_0016803)
**Label:** unspecified mitochondrial disorder

**Subclasses:** [MONDO:0011229](http://purl.obolibrary.org/obo/MONDO_0011229) (ethylmalonic encephalopathy), [MONDO:0010524](http://purl.obolibrary.org/obo/MONDO_0010524) (X-linked sideroblastic anemia with ataxia), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0055072](http://purl.obolibrary.org/obo/GO_0055072) (iron ion homeostasis), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0051213](http://purl.obolibrary.org/obo/GO_0051213) (dioxygenase activity), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0006749](http://purl.obolibrary.org/obo/GO_0006749) (glutathione metabolic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0050313](http://purl.obolibrary.org/obo/GO_0050313) (sulfur dioxygenase activity), [GO:0070813](http://purl.obolibrary.org/obo/GO_0070813) (hydrogen sulfide metabolic process), 

**Class expressions from DL-Learner:**

- [GO:0050313](http://purl.obolibrary.org/obo/GO_0050313) (sulfur dioxygenase activity) 62.50%
- [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane) 62.50%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 62.50%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 62.50%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 62.50%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044429](http://purl.obolibrary.org/obo/GO_0044429) (mitochondrial part) 62.50%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane) 62.50%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 62.50%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 62.50%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) and [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 62.50%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 62.50%


